Document Detail


Effects of exercise training on abdominal obesity and related metabolic complications.
MedLine Citation:
PMID:  8776009     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Excessive deposition of visceral adipose tissue is known to predispose to cardiovascular diseases. Considerable epidemiological and experimental evidence suggests that many physiological factors are involved in the aetiology of premature atherosclerosis associated with visceral obesity. Insulin resistance is frequently associated with abdominal obesity, and probably plays an important role in the pathophysiology of hypertriglyceridaemia, low levels of plasma high-density lipoprotein (HDL)-cholesterol, hypertension and reduced fibrinolytic activity. Exercise training may counteract the aberrant metabolic profile associated with abdominal obesity both directly and as a consequence of body fat loss. Exercise may increase insulin sensitivity, favourably alter the plasma lipoprotein profile and improve fibrinolytic activity. Changes in the activity of insulin-sensitive glucose transporters and of skeletal muscle lipoprotein lipase are some of the possible explanations for the increased insulin sensitivity and improved blood lipid profile associated with regular exercise. This review presents physical training as a relevant nonpharmacological tool in the treatment of abdominal obesity and associated metabolic disorders. The impact of regular exercise on the different aspects of the insulin resistance syndrome is discussed. The roles of gender, age and the state of insulin resistance on the metabolic effect of physical training are also considered.
Authors:
B Buemann; A Tremblay
Related Documents :
3522389 - Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant zucker obese...
11234459 - Obesity: preventing and managing the global epidemic. report of a who consultation.
15235769 - Single nucleotide polymorphisms of protein tyrosine phosphatase 1b gene are associated ...
18778119 - Use of somatostatin analogues in obesity.
1348469 - Effect of genetic dilution on development of diabetes, impaired glucose tolerance and i...
16855189 - Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweigh...
22346119 - The use of antivascular endothelial growth factor agents in the perioperative period in...
19828429 - Translating clinical guidelines into clinical practice: role of the pharmacist in type ...
19766209 - The role of family history in clinical symptoms and therapeutic outcomes of women with ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Sports medicine (Auckland, N.Z.)     Volume:  21     ISSN:  0112-1642     ISO Abbreviation:  Sports Med     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-11-21     Completed Date:  1996-11-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8412297     Medline TA:  Sports Med     Country:  NEW ZEALAND    
Other Details:
Languages:  eng     Pagination:  191-212     Citation Subset:  IM; S    
Affiliation:
Physical Activity Sciences Laboratory, PEPS, Laval University, Ste-Foy, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abdomen
Cardiovascular Diseases / physiopathology
Cholesterol / blood
Diabetes Mellitus, Type 2 / physiopathology
Exercise / physiology*
Female
Humans
Insulin Resistance
Male
Muscle, Skeletal / physiology
Myocardial Infarction / physiopathology
Obesity / blood,  physiopathology*
Chemical
Reg. No./Substance:
57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocke...
Next Document:  The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage.